Humanigen Inc
Biotechnology
Healthcare
HGEN
69.95 M shares
NASDAQ US
traded
12 Jul 2022
listed
yes
open
3.00
52 week high
17.83
high
3.19
52 week low
1.64
low
2.92
growth
-81.68 %
previous Close
3.02
P/E ratio
market cap
151 M
div yield
0
usd
Mar 2022
qoq
revenue
1.04 M
-0.10 %
net incoming
-21.28 M
36.56 %
eps
39.62 %
eps surprise
30.43 %
net profit margin
-2053.86 %
1180.00 %
operating incoming
-20.53 M
36.53 %
net change in cash
-1.07 M
-146.86 %
cash on hand
68.95 M
-1.53 %
cost of revenue
0.00 %
top top